129 related articles for article (PubMed ID: 25571292)
41. [Rhabdomyolysis in cardiac transplant recipient due to verapamil interaction with simvastatin and cyclosporin treatment].
Chiffoleau A; Trochu JN; Veyrac G; Petit T; Abadie P; Bourin M; Jolliet P
Therapie; 2003; 58(2):168-70. PubMed ID: 12942860
[No Abstract] [Full Text] [Related]
42. Prediction of cytochrome P450 3A inhibition by verapamil enantiomers and their metabolites.
Wang YH; Jones DR; Hall SD
Drug Metab Dispos; 2004 Feb; 32(2):259-66. PubMed ID: 14744949
[TBL] [Abstract][Full Text] [Related]
43. Effects of Silymarin on the In Vivo Pharmacokinetics of Simvastatin and Its Active Metabolite in Rats.
Li Y; Wu Y; Li YJ; Meng L; Ding CY; Dong ZJ
Molecules; 2019 Apr; 24(9):. PubMed ID: 31035343
[TBL] [Abstract][Full Text] [Related]
44. A population pharmacokinetic-pharmacodynamic model for simvastatin that predicts low-density lipoprotein-cholesterol reduction in patients with primary hyperlipidaemia.
Kim J; Ahn BJ; Chae HS; Han S; Doh K; Choi J; Jun YK; Lee YW; Yim DS
Basic Clin Pharmacol Toxicol; 2011 Sep; 109(3):156-63. PubMed ID: 21426490
[TBL] [Abstract][Full Text] [Related]
45. Different effects of St John's wort on the pharmacokinetics of simvastatin and pravastatin.
Sugimoto K; Ohmori M; Tsuruoka S; Nishiki K; Kawaguchi A; Harada K; Arakawa M; Sakamoto K; Masada M; Miyamori I; Fujimura A
Clin Pharmacol Ther; 2001 Dec; 70(6):518-24. PubMed ID: 11753267
[TBL] [Abstract][Full Text] [Related]
46. Simvastatin-diltiazem drug interaction resulting in rhabdomyolysis and hepatitis.
Kanathur N; Mathai MG; Byrd RP; Fields CL; Roy TM
Tenn Med; 2001 Sep; 94(9):339-41. PubMed ID: 11550401
[TBL] [Abstract][Full Text] [Related]
47. Pharmacokinetic-pharmacodynamic drug interactions with HMG-CoA reductase inhibitors.
Williams D; Feely J
Clin Pharmacokinet; 2002; 41(5):343-70. PubMed ID: 12036392
[TBL] [Abstract][Full Text] [Related]
48. A population pharmacokinetic model for simvastatin and its metabolites in children and adolescents.
Ogungbenro K; Wagner JB; Abdel-Rahman S; Leeder JS; Galetin A
Eur J Clin Pharmacol; 2019 Sep; 75(9):1227-1235. PubMed ID: 31172248
[TBL] [Abstract][Full Text] [Related]
49. Analysis of secondary care data to evaluate the clinical relevance of the drug-drug interaction between amlodipine and simvastatin.
Fuhrmann S; Koppen A; Seeling A; Knoth H; Schröder J
Z Evid Fortbild Qual Gesundhwes; 2019 Oct; 146():21-27. PubMed ID: 31324418
[TBL] [Abstract][Full Text] [Related]
50. Pharmacokinetics of verapamil and its major metabolite, norverapamil from oral administration of verapamil in rabbits with hepatic failure induced by carbon tetrachloride.
Choi JS; Burm JP
Arch Pharm Res; 2005 Apr; 28(4):483-7. PubMed ID: 15918524
[TBL] [Abstract][Full Text] [Related]
51. Effect of naringin pretreatment on bioavailability of verapamil in rabbits.
Yeum CH; Choi JS
Arch Pharm Res; 2006 Jan; 29(1):102-7. PubMed ID: 16491851
[TBL] [Abstract][Full Text] [Related]
52. Identification of the effect of multiple polymorphisms on the pharmacokinetics of simvastatin and simvastatin acid using a population-modeling approach.
Tsamandouras N; Dickinson G; Guo Y; Hall S; Rostami-Hodjegan A; Galetin A; Aarons L
Clin Pharmacol Ther; 2014 Jul; 96(1):90-100. PubMed ID: 24598718
[TBL] [Abstract][Full Text] [Related]
53. Pharmacokinetic parameters of verapamil and its active metabolite norverapamil in patients with hepatopathy.
Vlcek J; Macek K; Hůlek P; Brátová M; Fendrich Z
Arzneimittelforschung; 1995 Feb; 45(2):146-9. PubMed ID: 7710436
[TBL] [Abstract][Full Text] [Related]
54. The interaction of diltiazem with simvastatin.
Mousa O; Brater DC; Sunblad KJ; Hall SD
Clin Pharmacol Ther; 2000 Mar; 67(3):267-74. PubMed ID: 10741630
[TBL] [Abstract][Full Text] [Related]
55. Evaluation of a pharmacokinetic interaction between valsartan and simvastatin in healthy subjects.
Sunkara G; Reynolds CV; Pommier F; Humbert H; Yeh C; Prasad P
Curr Med Res Opin; 2007 Mar; 23(3):631-40. PubMed ID: 17355744
[TBL] [Abstract][Full Text] [Related]
56. Calcium channel blocker-simvastatin interaction.
Tobert JA; Vega JM; Dobrinska M; Gruer PJ
Clin Pharmacol Ther; 1999 May; 65(5):583-5. PubMed ID: 10340925
[No Abstract] [Full Text] [Related]
57. Comparative pharmacokinetics of verapamil and norverapamil in normal and ulcerative colitis rats after oral administration of low and high dose verapamil by UPLC-MS/MS.
Yao H; Wang C; Lu W; Li W; Jing W; Zhang J; Yang G; Zeng A
Xenobiotica; 2020 Jun; 50(6):713-721. PubMed ID: 31633443
[TBL] [Abstract][Full Text] [Related]
58. Carbamazepine markedly reduces serum concentrations of simvastatin and simvastatin acid.
Ucar M; Neuvonen M; Luurila H; Dahlqvist R; Neuvonen PJ; Mjörndal T
Eur J Clin Pharmacol; 2004 Feb; 59(12):879-82. PubMed ID: 14691614
[TBL] [Abstract][Full Text] [Related]
59. Rhabdomyolysis and acute renal failure in a cardiac transplant recipient due to multiple drug interactions.
Kusus M; Stapleton DD; Lertora JJ; Simon EE; Dreisbach AW
Am J Med Sci; 2000 Dec; 320(6):394-7. PubMed ID: 11149552
[TBL] [Abstract][Full Text] [Related]
60. Drug interactions with lipid-lowering drugs: mechanisms and clinical relevance.
Neuvonen PJ; Niemi M; Backman JT
Clin Pharmacol Ther; 2006 Dec; 80(6):565-81. PubMed ID: 17178259
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
